Principal Financial Group
VTAK icon

Principal Financial Group’s Catheter Precision VTAK Stock Holding History

Principal Financial Group’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2
Closed -$233K – 2359
2020
Q2 		$233K Hold
2
– – ﹤0.01% 2145
2020
Q1 		$529K Hold
2
– – ﹤0.01% 1859
2019
Q4 		$598K Hold
2
– – ﹤0.01% 1913
2019
Q3 		$739K Hold
2
– – ﹤0.01% 1870
2019
Q2 		$1.93M Buy
2
+1
+100% +$911K ﹤0.01% 1727
2019
Q1 		$974K Hold
1
– – ﹤0.01% 1833
2018
Q4 		$2.43M Hold
1
– – ﹤0.01% 1690
2018
Q3 		$4.26M Buy
+1
New +$4.54M ﹤0.01% 1647

Other funds holding VTAK

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Weil Company San Diego, California $568M AUM 19.88% 1-Year Est. Return

Principal Financial Group's VTAK Position: Q3 2020 in Review

Principal Financial Group sold out of Catheter Precision (VTAK) in Q3 2020, closing a stake of 2 shares — an estimated $233K sold.

Principal Financial Group first reported a position in VTAK in Q3 2018 and held it in 8 quarters. The position peaked at $4.26M in Q3 2018. 8 funds tracked by Wall St. Rank hold VTAK as of Q3 2020.

  • Principal Financial Group reported no remaining Catheter Precision position as of Q3 2020 after selling out during the quarter.
  • Principal Financial Group sold 2 Catheter Precision shares in Q3 2020, an estimated $233K.
  • Principal Financial Group first reported a position in Catheter Precision in Q3 2018 and held it in 8 quarters.
  • Principal Financial Group's Catheter Precision position peaked at $4.26M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2020.

Based on Principal Financial Group's 13F filing for Q3 2020, filed 6 Nov 2020.